Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Cohen & Steers, Inc. (CNS) Going to Burn These Hedge Funds?

Page 1 of 2

What’s a smart Cohen & Steers, Inc. (NYSE:CNS) investor to do?

At the moment, there are many gauges shareholders can use to watch the equity markets. A duo of the most useful are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite hedge fund managers can trounce their index-focused peers by a very impressive margin (see just how much).

Cohen & Steers, Inc. (NYSE:CNS)

Just as key, optimistic insider trading sentiment is another way to look at the marketplace. Just as you’d expect, there are a variety of stimuli for a corporate insider to cut shares of his or her company, but just one, very clear reason why they would buy. Many academic studies have demonstrated the useful potential of this method if shareholders know where to look (learn more here).

Now that that’s out of the way, it’s important to analyze the newest info for Cohen & Steers, Inc. (NYSE:CNS).

How have hedgies been trading Cohen & Steers, Inc. (NYSE:CNS)?

In preparation for the third quarter, a total of 6 of the hedge funds we track held long positions in this stock, a change of 0% from the previous quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were upping their stakes significantly.

Out of the hedge funds we follow, Mario Gabelli’s GAMCO Investors had the largest position in Cohen & Steers, Inc. (NYSE:CNS), worth close to $49.4 million, comprising 0.3% of its total 13F portfolio. The second largest stake is held by Chuck Royce of Royce & Associates, with a $34.8 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Some other hedgies with similar optimism include Ken Griffin’s Citadel Investment Group, D. E. Shaw’s D E Shaw and John Zaro’s Bourgeon Capital.

Since Cohen & Steers, Inc. (NYSE:CNS) has experienced bearish sentiment from the smart money’s best and brightest, logic holds that there was a specific group of fund managers who were dropping their positions entirely at the end of the second quarter. Intriguingly, Jim Simons’s Renaissance Technologies cut the largest position of the 450+ funds we key on, valued at an estimated $1.9 million in stock, and Israel Englander of Millennium Management was right behind this move, as the fund dumped about $0.2 million worth. These moves are important to note, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

How are insiders trading Cohen & Steers, Inc. (NYSE:CNS)?

Legal insider trading, particularly when it’s bullish, is particularly usable when the company in question has seen transactions within the past 180 days. Over the last half-year time period, Cohen & Steers, Inc. (NYSE:CNS) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also take a look at the relationship between both of these indicators in other stocks similar to Cohen & Steers, Inc. (NYSE:CNS). These stocks are WisdomTree Investments, Inc. (NASDAQ:WETF), Gamco Investors Inc. (NYSE:GBL), Janus Capital Group Inc (NYSE:JNS), Virtus Investment Partners Inc (NASDAQ:VRTS), and Financial Engines Inc (NASDAQ:FNGN). This group of stocks belong to the asset management industry and their market caps resemble CNS’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!